Approval · Notice of Compliance 5702 · 1994
DILAUDID: Notice of Compliance 5702
Issued May 9, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5702
- Date
- May 9, 1994
- Company
- Knoll Pharma Inc.Markham, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New dosage form
- Therapeutic class
- Narcotic analgesic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DILAUDID | 02085895 | Cancelled Post Market |
Medicinal ingredients
- HYDROMORPHONE HCL 250 MG per VIAL